查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1771678

胜肽合成市场规模、份额、趋势分析报告：按产品、应用、技术、最终用途、地区和细分市场预测，2025 年至 2033 年

Peptide Synthesis Market Size, Share & Trends Analysis Report By Product, By Application, By Technology, By End-use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

胜肽合成市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，预计到2033年，全球胜肽合成市场规模将达到18.406亿美元，2025年至2033年的复合年增长率为7.71%。针对肽疗法开发的重大研究和技术创新将在不久的将来推动市场成长。此外，肽合成技术的不断进步预计将为在该市场企业发展的公司提供丰厚的利润机会。

近年来，对客製化胜肽合成的需求激增，许多公司都致力于提供与客製化胜肽合成相关的产品和服务。例如，总部位于英国的Almac集团就提供研究应用的胜肽合成服务。客製化胜肽需求的不断增长以及市场格局的演变，为市场成长提供了丰厚的利润机会。供应商正在扩大产能，以满足研究和治疗领域对高品质胜肽日益增长的需求。

製药公司专注于开发新型生技药品，并将胜肽类药物从研发管线阶段推进至商业化规模，将进一步促进市场成长。越来越多的研究活动致力于探索高品质胜肽和胜肽库在疫苗开发和生物标记发现中的潜力，这为全球胜肽合成市场的收益做出了巨大贡献。此外，随着稳定性和药物动力学特性增强的改性胜肽（GMP肽）的市场引入，预计在整个预测期内，市场将保持两位数的成长。

近年来，随着心血管疾病和代谢疾病患者数量的大幅增加，治疗性胜肽的发展取得了显着增长，这极大地促进了活性胜肽的发现，进一步刺激了市场需求。

肽合成市场报告重点

  • 试剂和消耗品等产品部分在胜肽合成市场占据主导地位，2024 年的收益占有率为 47.97%。预计设备部分在预测期内将实现显着的复合年增长率。
  • 液相肽合成 (LPPS) 技术领域在胜肽合成市场占据主导地位，2024 年的收益占有率为 44.04%。在胜肽合成市场中，混合技术领域预计在预测期内将实现最快的复合年增长率。
  • 治疗药物将占据市场主导地位，2024 年的收益占有率将达到 70.35%。在胜肽合成市场中，诊断应用领域预计在预测期内将实现最快的复合年增长率。
  • 预计製药和生物技术公司将引领市场，到 2024 年将占据 66.74% 的收益占有率。在胜肽合成产业的最终用途领域，合约研究和开发组织 (CDMOs 和 CRO) 预计在预测期内将实现最快的复合年增长率。
  • 2024 年，北美胜肽合成占据全球市场主导地位，收益占有率最大，为 38.95%。预计在预测期内，亚太肽合成市场将以 9.33% 的复合年增长率实现最快成长。

目录

第一章调查方法与范围

第二章执行摘要

第三章市场变数、趋势和范围

  • 市场血统
    • 母市场分析
    • 辅助市场分析
  • 胜肽合成－市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 市场分析工具
    • 波特五力分析
    • SWOT分析：依因素（政治/法律、经济、技术）
    • COVID-19影响分析

第四章胜肽合成市场：产品业务分析

  • 产品细分仪表板
  • 2024 年和 2033 年全球胜肽合成市场产品变化分析
  • 全球胜肽合成市场规模及趋势分析（按产品，2021-2033）
  • 装置
  • 试剂和耗材
  • 服务

第五章胜肽合成市场：技术业务分析

  • 技术细分仪表板
  • 2024年及2033年全球胜肽合成市场趋势分析（按技术）
  • 2021-2033 年全球胜肽合成市场规模及趋势分析（按技术）
  • 固相胜肽合成（SPPS）
  • 液相肽合成（LPPS）
  • 混合技术

第六章胜肽合成市场：应用业务分析

  • 应用程式细分仪表板
  • 2024年及2033年全球胜肽合成市场应用趋势分析
  • 全球胜肽合成市场规模及应用趋势分析（2021-2033）
  • 治疗
  • 诊断
  • 调查

7. 胜肽合成市场：最终用途业务分析

  • 最终用途细分仪表板
  • 2024 年和 2033 年全球胜肽合成市场最终用途变化分析
  • 2021-2033 年全球胜肽合成市场规模及趋势分析（依最终用途）
  • 製药和生物技术公司
  • CDMO/CRO
  • 学术研究所

第八章胜肽合成市场：按产品、技术、应用和最终用途的区域估计和趋势分析

  • 区域市场仪表板
  • 2024 年及 2033 年区域市场占有率分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争态势

  • 公司/竞争对手分类
  • 战略地图
  • 2024年企业市场分析
  • 公司简介/上市公司
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • GenScript
    • Bachem Holding AG
    • Biotage
    • Creative Diagnostics
    • PolyPeptide Group
    • Syngene International Limited
    • Puresynth Research Chemicals Pvt Ltd.
    • Lonza
Product Code: GVR-3-68038-697-4

Peptide Synthesis Market Growth & Trends:

The global peptide synthesis market size is expected to reach USD 1,840.6 million by 2033, registering a CAGR of 7.71% from 2025 to 2033, according to a new report by Grand View Research, Inc. Significant research and innovation targeted towards the development of peptide therapeutics is set to boost the market growth in the near future. Additionally, increasing advancements in the peptide synthesis technologies is expected to offer profitable opportunities for the companies operating in the market.

A surge in the demand for custom peptide synthesis has been observed in the recent years; several companies operating in this industry offer products and services associated with custom peptide synthesis. For instance, a UK based company namely, Almac Group offers peptide synthesis suitable for research use. Constantly growing demand and evolving market landscape for custom peptides is set to offer lucrative opportunities for the market growth. The suppliers are expanding their production capacity to suffice the increasing demand for high quality peptides across research and therapeutics areas.

Rising focus of the pharmaceutical companies towards the development of novel biologics and shifting the peptide drugs from the pipeline stage to commercial scale further strengthens the market growth. Increase in the number of research activities performed on exploring the potential of high-quality peptides and peptide libraries in the development of vaccines and biomarker discovery heavily contributes to the revenue generated by the global peptide synthesis market. Moreover, introduction of modified peptides (GMP peptides) that possess enhanced stability and pharmacokinetic properties in the market is expected to maintain the double-digit market growth throughout the forecast period.

Therapeutic peptide development has witnessed remarkable growth in the recent years, this is further driven by significant increase in the patient pool suffering from cardiovascular and metabolic diseases. This has propelled the discovery of bioactive peptides exponentially which further drives the market demand.

Peptide Synthesis Market Report Highlights:

  • The reagents and consumables in the product segment dominated the peptide synthesis market with a revenue share of 47.97% in 2024. The equipment segment is expected to register a significant CAGR during the forecast period.
  • The technology segment's liquid phase peptide synthesis (LPPS) dominated the peptide synthesis market with a revenue share of 44.04% in 2024. The hybrid technology segment in the peptide synthesis market is expected to register the fastest CAGR during the forecast period
  • Therapeutics dominated the market with a revenue share of 70.35% in 2024. The diagnosis application segment in the peptide synthesis market is expected to register the fastest CAGR during the forecast period.
  • Pharmaceutical and biotechnology companies led the market with a revenue share of 66.74% in 2024. The Contract Development & Manufacturing Organization & Contract Research Organization (CDMOs & CROs) in the end-use segment in the peptide synthesis industry are expected to register the fastest CAGR during the forecast period.
  • North America peptide synthesis dominated the global market with the largest revenue share of 38.95% in 2024. The peptide synthesis market in Asia Pacific is expected to register the fastest growth, with a CAGR of 9.33% during the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Technology Segment
    • 1.2.3. Application Segment
    • 1.2.4. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segmental Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, and Scope

  • 3.1. Market Lineage
    • 3.1.1. Parent Market Analysis
    • 3.1.2. Ancillary Market Analysis
  • 3.2. Peptide Synthesis- Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Market Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Peptide Synthesis Market: Product Business Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Global Peptide Synthesis Market Product Movement Analysis, 2024 & 2033
  • 4.3. Global Peptide Synthesis Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Equipment
    • 4.4.1. Global Equipment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Peptide Synthesizers
      • 4.4.2.1. Global Peptide Synthesizers Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Lyophilizers
      • 4.4.3.1. Global Lyophilizers Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Chromatography Equipment
      • 4.4.4.1. Global Chromatography Equipment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Global Others Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Reagents & Consumables
    • 4.5.1. Reagents & Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Resins
      • 4.5.2.1. Global Resins Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Amino Acids
      • 4.5.3.1. Global Amino Acids Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 4.5.4. Coupling Reagents
      • 4.5.4.1. Global Coupling Reagents Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 4.5.5. Dyes & Fluorescent Labeling Reagents
      • 4.5.5.1. Global Dyes & Fluorescent Labeling Reagents Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 4.5.6. Others
      • 4.5.6.1. Global Others Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Services
      • 4.6.1.1. Global Services Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Peptide Synthesis Market: Technology Business Analysis

  • 5.1. Technology Segment Dashboard
  • 5.2. Global Peptide Synthesis Market Technology Movement Analysis, 2024 & 2033
  • 5.3. Global Peptide Synthesis Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
  • 5.4. Solid Phase Peptide Synthesis (SPPS)
    • 5.4.1. Global Solid Phase Peptide Synthesis (SPPS) Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Liquid Phase Peptide Synthesis (LPPS)
    • 5.5.1. Global Liquid Phase Peptide Synthesis (LPPS) Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Hybrid Technology
    • 5.6.1. Global Hybrid Technology Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Peptide Synthesis Market: Application Business Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. Global Peptide Synthesis Market Application Movement Analysis, 2024 & 2033
  • 6.3. Global Peptide Synthesis Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Therapeutics
    • 6.4.1. Global Therapeutics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. Cancer
      • 6.4.2.1. Global Cancer Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Metabolic
      • 6.4.3.1. Global Metabolic Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Cardiovascular Disorder
      • 6.4.4.1. Global Cardiovascular Disorder Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 6.4.5. Respiratory
      • 6.4.5.1. Global Respiratory Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 6.4.6. GIT (Gastrointestinal Disorders)
      • 6.4.6.1. Global GIT (Gastrointestinal Disorders) Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 6.4.7. Infectious Disease
      • 6.4.7.1. Global Infectious Disease Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 6.4.8. Pain
      • 6.4.8.1. Global Pain Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 6.4.9. Dermatology
      • 6.4.9.1. Global Dermatology Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 6.4.10. CNS
      • 6.4.10.1. Global CNS Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 6.4.11. Renal
      • 6.4.11.1. Global Renal Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 6.4.12. Others
      • 6.4.12.1. Global Others Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Diagnosis
    • 6.5.1. Global Diagnosis Peptide Synthesis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Research
    • 6.6.1. Global Research Peptide Synthesis Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Peptide Synthesis Market: End Use Business Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. Global Peptide Synthesis Market End Use Movement Analysis, 2024 & 2033
  • 7.3. Global Peptide Synthesis Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Pharmaceutical & Biotechnology Companies
    • 7.4.1. Global Pharmaceutical & Biotechnology Companies Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.5. CDMOs/CROs
    • 7.5.1. Global CDMOs/CROs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Academic and Research Institutions
    • 7.6.1. Global Academic and Research Institutions Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Peptide Synthesis Market: Regional Estimates & Trend Analysis by Product, Technology, Application, and End Use

  • 8.1. Regional Market Dashboard
  • 8.2. Regional Market Share Analysis, 2024 & 2033
  • 8.3. North America
    • 8.3.1. North America market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Target Disease Prevalence
      • 8.3.2.3. Competitive scenario
      • 8.3.2.4. Regulatory framework
      • 8.3.2.5. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Target disease prevalence
      • 8.3.3.3. Competitive scenario
      • 8.3.3.4. Regulatory framework
      • 8.3.3.5. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key country dynamics
      • 8.3.4.2. Target disease prevalence
      • 8.3.4.3. Competitive scenario
      • 8.3.4.4. Regulatory framework
      • 8.3.4.5. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Target disease prevalence
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Regulatory framework
      • 8.4.2.5. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Target disease prevalence
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. Regulatory framework
      • 8.4.3.5. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Target disease prevalence
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Regulatory framework
      • 8.4.4.5. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Target disease prevalence
      • 8.4.5.3. Competitive scenario
      • 8.4.5.4. Regulatory framework
      • 8.4.5.5. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Target disease prevalence
      • 8.4.6.3. Competitive scenario
      • 8.4.6.4. Regulatory framework
      • 8.4.6.5. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Target disease prevalence
      • 8.4.7.3. Competitive scenario
      • 8.4.7.4. Regulatory framework
      • 8.4.7.5. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Target disease prevalence
      • 8.4.8.3. Competitive scenario
      • 8.4.8.4. Regulatory framework
      • 8.4.8.5. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key country dynamics
      • 8.4.9.2. Target disease prevalence
      • 8.4.9.3. Competitive scenario
      • 8.4.9.4. Regulatory framework
      • 8.4.9.5. Norway market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Target disease prevalence
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Regulatory framework
      • 8.5.2.5. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Target disease prevalence
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Regulatory framework
      • 8.5.3.5. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Target disease prevalence
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Regulatory framework
      • 8.5.4.5. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.5. Australia
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Target disease prevalence
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. Regulatory framework
      • 8.5.5.5. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.6. South Korea
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Target disease prevalence
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Regulatory framework
      • 8.5.6.5. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Target disease prevalence
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. Regulatory framework
      • 8.5.7.5. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Target disease prevalence
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Regulatory framework
      • 8.6.2.5. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Target disease prevalence
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. Regulatory framework
      • 8.6.3.5. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Target disease prevalence
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Regulatory framework
      • 8.7.2.5. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Target disease prevalence
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. Regulatory framework
      • 8.7.3.5. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Target disease prevalence
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Regulatory framework
      • 8.7.4.5. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Target disease prevalence
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. Regulatory framework
      • 8.7.5.5. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Company Profiles/Listing
    • 9.4.1. Thermo Fisher Scientific Inc.
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Technology benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Merck KGaA
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Technology benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. GenScript
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Technology benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Bachem Holding AG
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Technology benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Biotage
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Technology benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Creative Diagnostics
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Technology benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. PolyPeptide Group
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Technology benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Syngene International Limited
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Technology benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Puresynth Research Chemicals Pvt Ltd.
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Technology benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Lonza
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Technology benchmarking
      • 9.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Regulatory Framework
  • Table 4 Global Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 5 Global Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 6 Global Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 7 Global Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 8 Global Peptide Synthesis Market, By region, 2021 - 2033 (USD Million)
  • Table 9 North America Peptide Synthesis Market, By country, 2021 - 2033 (USD Million)
  • Table 10 North America Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 11 North America Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 12 North America Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 13 North America Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 14 U.S. Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 15 U.S. Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 16 U.S. Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 17 U.S. Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 18 Canada Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 19 Canada Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 20 Canada Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 21 Canada Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 22 Mexico Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 23 Mexico Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 24 Mexico Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 25 Mexico Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 26 Europe Peptide Synthesis Market, By country, 2021 - 2033 (USD Million)
  • Table 27 Europe Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 28 Europe Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 29 Europe Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 30 Europe Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 31 UK Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 32 UK Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 33 UK Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 34 UK Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 35 Germany Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 36 Germany Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 37 Germany Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 38 Germany Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 39 France Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 40 France Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 41 France Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 42 France Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 43 Spain Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 44 Spain Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 45 Spain Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 46 Spain Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 47 Italy Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 48 Italy Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 49 Italy Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 50 Italy Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 51 Denmark Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 52 Denmark Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 53 Denmark Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 54 Denmark Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 55 Norway Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 56 Norway Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 57 Norway Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 58 Norway Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 59 Sweden Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 60 Sweden Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 61 Sweden Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 62 Sweden Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Peptide Synthesis Market, By country, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 66 Asia Pacific Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 67 Asia Pacific Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 68 China Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 69 China Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 70 China Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 71 China Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 72 Japan Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 73 Japan Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 74 Japan Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 75 Japan Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 76 India Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 77 India Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 78 India Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 79 India Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 80 South Korea Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 81 South Korea Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 82 South Korea Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 83 South Korea Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 84 Australia Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 85 Australia Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 86 Australia Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 87 Australia Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 88 Thailand Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 89 Thailand Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 90 Thailand Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 91 Thailand Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 92 Latin America Peptide Synthesis Market, By country, 2021 - 2033 (USD Million)
  • Table 93 Latin America Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 94 Latin America Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 95 Latin America Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 96 Latin America Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 97 Brazil Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 98 Brazil Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 99 Brazil Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 100 Brazil Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 101 Argentina Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 102 Argentina Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 103 Argentina Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 104 Argentina Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 105 MEA Peptide Synthesis Market, By country, 2021 - 2033 (USD Million)
  • Table 106 MEA Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 107 MEA Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 108 MEA Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 109 MEA Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 110 South Africa Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 111 South Africa Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 112 South Africa Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 113 South Africa Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 114 UAE Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 115 UAE Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 116 UAE Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 117 UAE Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 118 Saudi Arabia Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 119 Saudi Arabia Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 120 Saudi Arabia Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 121 Saudi Arabia Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 122 Kuwait Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 124 Kuwait Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 125 Kuwait Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Peptide synthesis market segmentation
  • Fig. 2 Information procurement
  • Fig. 3 Data analysis models
  • Fig. 4 Market formulation and validation
  • Fig. 5 Data validating & publishing
  • Fig. 6 Market research process
  • Fig. 7 Information procurement
  • Fig. 8 Primary research
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Peptide synthesis market: product outlook key takeaways
  • Fig. 13 Peptide synthesis market: product movement analysis
  • Fig. 14 Global equipment market, 2021 - 2033 (USD Million)
  • Fig. 15 Global reagents & consumables market, 2021 - 2033 (USD Million)
  • Fig. 16 Global services market, 2021 - 2033 (USD Million)
  • Fig. 17 Peptide synthesis market: Technology outlook and key takeaways
  • Fig. 18 Peptide synthesis market: Technology movement analysis
  • Fig. 19 Global solid phase Peptide Synthesis (SPPS) market, 2021 - 2033 (USD Million)
  • Fig. 20 Global liquid phase Peptide Synthesis (LPPS) market, 2021 - 2033 (USD Million)
  • Fig. 21 Global hybrid technology market, 2021 - 2033 (USD Million)
  • Fig. 22 Peptide synthesis market: application outlook and key takeaways
  • Fig. 23 Peptide synthesis market: application movement analysis
  • Fig. 24 Global Therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 25 Global Diagnosis market, 2021 - 2033 (USD Million)
  • Fig. 26 Global research applications market, 2021 - 2033 (USD Million)
  • Fig. 27 Peptide Synthesis market: End-use outlook and key takeaways
  • Fig. 28 Peptide Synthesis market: End-use movement analysis
  • Fig. 29 Global pharmaceutical & biotechnology companies market, 2021 - 2033 (USD Million)
  • Fig. 30 Global CDMOs & CROs market, 2021 - 2033 (USD Million)
  • Fig. 31 Global academic & research institutes market, 2021 - 2033 (USD Million)
  • Fig. 32 Regional marketplace: Key takeaways
  • Fig. 33 Regional marketplace: Key takeaways
  • Fig. 34 North America Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Key country dynamics
  • Fig. 36 U.S. Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 Canada Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 Mexico Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 Europe Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Germany Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 UK Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 France Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Italy Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Spain Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Market scenario
  • Fig. 54 Key country dynamics
  • Fig. 55 Denmark Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Regulatory framework
  • Fig. 57 Key country dynamics
  • Fig. 58 Norway Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Regulatory framework
  • Fig. 60 Key country dynamics
  • Fig. 61 Sweden Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Regulatory framework
  • Fig. 63 Asia Pacific Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Japan Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 China Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 India Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Australia Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Thailand Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 South Korea Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Latin America Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Brazil Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Argentina Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 MEA Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 South Africa Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Saudi Arabia Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 UAE Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Kuwait Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)